Biological Products, Except Diagnostic Substances (Biotech) - Latest Activist Disclosures

This table shows recent activist investor (Schedule 13D) filings made in this industry. Any investor or hedge fund that makes an investment with the intention of influencing management is considered an activist investor and must file a 13D.

Date Form Target Company Investor Shares Ownership
(Percent)		 Ownership Change
(Percent)
2024-10-02 13D/A BCAB / BioAtla, Inc. Soleus Private Equity Fund I, L.P. 1,237,909 2.56 -53.26
2024-10-01 13D/A ZIVOW / ZIVO Bioscience, Inc. - Equity Warrant Hep Investments Llc 530,989 15.34
2024-09-24 13D/A GLUE / Monte Rosa Therapeutics, Inc. Versant Venture Capital VI, L.P. 5,099,336 8.30 -25.00
2024-09-20 13D/A VALN / Valneva SE - Depositary Receipt (Common Stock) Bpifrance Participations SA 14,113,834 8.60 10.25
2024-09-06 13D/A BCAB / BioAtla, Inc. Soleus Private Equity Fund I, L.P. 2,648,472 5.50 -32.11
2024-09-05 13D/A ATRA / Atara Biotherapeutics, Inc. Adiumentum Capital Fund I LP 1,134,322 19.99 -85.94
2024-09-03 13D/A HUMA / Humacyte, Inc. Niklason Laura E 7,705,473 6.30 -16.13
2024-08-22 13D/A KYMR / Kymera Therapeutics, Inc. Baker Bros. Advisors Lp 6,001,262 9.30 0.06
2024-08-21 13D/A TTNP / Titan Pharmaceuticals, Inc. Sire Group Ltd. 150,087 14.10 0.00
2024-08-20 13D/A ELOX / Eloxx Pharmaceuticals, Inc. Advent Life Sciences LLP 124,972 3.98 -95.06
2024-08-19 13D/A ENZN / Enzon Pharmaceuticals, Inc. Icahn Carl C
2024-08-14 13D/A MGTX / MeiraGTx Holdings plc Perceptive Advisors Llc 12,696,562 16.40 10.96
2024-08-12 13D/A GLUE / Monte Rosa Therapeutics, Inc. New Enterprise Associates 17, L.P. 7,774,930 12.70 -0.13
2024-08-12 13D/A GLUE / Monte Rosa Therapeutics, Inc. Versant Venture Capital VI, L.P. 6,799,115 11.10 0.00
2024-08-12 13D/A CASI / CASI Pharmaceuticals, Inc. He Wei-Wu 3,257,891 20.94 14.80
2024-08-09 13D/A PASG / Passage Bio, Inc. Versant Venture Capital VI, L.P. 0 0.00 -100.00
2024-08-08 13D/A BDTX / Black Diamond Therapeutics, Inc. Versant Venture Capital VI, L.P. 4,328,883 7.70 0.00
2024-07-25 13D CDTX / Cidara Therapeutics, Inc. Ra Capital Management, L.p. 703,080 9.99
2024-07-17 13D/A PHGE / BiomX Inc. OrbiMed Israel BioFund GP Limited Partnership 17,877,653 9.99 42.14
2024-07-11 13D/A PHGE / BiomX Inc. Flynn James E 155,584,448 9.99 2,446.35
2024-06-25 13D/A PROK / ProKidney Corp. Control Empresarial de Capitales S.A. de C.V. 71,560,107 25.30 13.37
2024-06-14 13D/A PROK / ProKidney Corp. Tolerantia, LLC 111,257,870 38.70 25.52
2024-06-12 13D ZIVO / ZIVO Bioscience, Inc. Cornell Alison A 242,212 7.40
2024-06-12 13D ZIVO / ZIVO Bioscience, Inc. Payne John Bernard 305,871 8.50
2024-06-12 13D ZIVO / ZIVO Bioscience, Inc. Marchiando Keith 341,616 9.40
2024-06-12 13D/A SLDB / Solid Biosciences Inc. Ra Capital Management, L.p. 4,358,478 11.30 0.22
2024-06-11 13D/A SLDB / Solid Biosciences Inc. BCLS SB Investco, LP 2,301,955 6.00 0.00
2024-06-10 13D/A TBIO / Telesis Bio, Inc. Northpond Ventures, LP 1,032,874 47.60 -94.36
2024-06-10 13D/A TBIO / Telesis Bio, Inc. Novalis LifeSciences Investments II, L.P. 420,435 19.99 -94.33
2024-06-07 13D/A ZIVO / ZIVO Bioscience, Inc. Maggiore Christopher D. 458,371 14.00 29.06
2024-06-06 13D IMTX / Immatics N.V. Perceptive Advisors Llc 8,170,846 7.90
2024-06-04 13D/A HUMA / Humacyte, Inc. Niklason Laura E 9,186,901 7.60 -9.52
2024-06-03 13D INBX / Inhibrx Biosciences, Inc. Kayyem Jon Faiz 818,575 5.65
2024-06-03 13D INBX / Inhibrx Biosciences, Inc. Lappe Mark 761,413 5.26
2024-05-31 13D/A HLVX / HilleVax, Inc. Frazier Life Sciences Public Fund, L.P. 10,639,562 21.40 8.50
2024-05-30 13D/A PHGE / BiomX Inc. Flynn James E 6,110,098 8.75 0.00
2024-05-29 13D/A PASG / Passage Bio, Inc. Versant Venture Capital VI, L.P. 4,026,417 6.50 0.00
2024-05-22 13D ATRA / Atara Biotherapeutics, Inc. Adiumentum Capital Fund I LP 8,065,923 6.70
2024-05-21 13D/A AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock) Blackstone Group Inc 23,750,917 8.80 0.00
2024-05-21 13D/A CLLS / Cellectis S.A. - Depositary Receipt (Common Stock) Bpifrance Participations SA 6,913,153 6.90 0.00
2024-05-20 13D/A NVAX / Novavax, Inc. Shah Capital Management 11,031,176 7.90 2.46
2024-05-14 13D/A ADVM / Adverum Biotechnologies, Inc. Versant Ventures IV, LLC 500,387 2.40 -90.00
2024-05-13 13D/A GLUE / Monte Rosa Therapeutics, Inc. New Enterprise Associates 17, L.P. 7,784,930 15.40 1.17
2024-05-13 13D/A BDTX / Black Diamond Therapeutics, Inc. New Enterprise Associates 16, L.P. 4,546,947 8.10 31.84
2024-05-09 13D/A BDTX / Black Diamond Therapeutics, Inc. Ra Capital Management, L.p. 2,788,028 4.95 7.65
2024-05-08 13D/A EXEL / Exelixis, Inc. Farallon Capital Partners, L.P. 26,769,500 9.20 3.52
2024-05-07 13D/A NVAX / Novavax, Inc. Shah Capital Management 10,766,176 7.70 14.74
2024-05-06 13D/A CSBR / Champions Oncology, Inc. New Enterprise Associates 14, L.P. 1,713,720 12.60 -94.10
2024-05-03 13D KYTX / Kyverna Therapeutics, Inc. Vida Ventures, LLC 4,777,060 11.10
2024-04-26 13D/A CA:APS / Aptose Biosciences Inc. Hanmi Pharmaceutical Co., Ltd. 2,989,415 19.02